Hannah Hudson

3PUBLICATIONS
25CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 24, 2026
NLRP1B is an integrated decoy that subverts Shigella flexneri E3 ligase activity to promote effector-triggered immunity.

Siwon Chung, Hannah Hudson, Kaitlin A Stromberg

|Oct 06, 2021
Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma.

Edikan A Ogunnaike, Alain Valdivia, Mostafa Yazdimamaghani

Pageof 1